irbesartan and hydrochlorothiazide
Generic: irbesartan and hydrochlorothiazide
Labeler: unichem pharmaceuticals (usa), inc.Drug Facts
Product Profile
Brand Name
irbesartan and hydrochlorothiazide
Generic Name
irbesartan and hydrochlorothiazide
Labeler
unichem pharmaceuticals (usa), inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
hydrochlorothiazide 12.5 mg/1, irbesartan 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
29300-216
Product ID
29300-216_a2e7c9d1-50c4-4a14-8dd5-8dfc6d63a29a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207018
Listing Expiration
2026-12-31
Marketing Start
2017-09-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
29300216
Hyphenated Format
29300-216
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
irbesartan and hydrochlorothiazide (source: ndc)
Generic Name
irbesartan and hydrochlorothiazide (source: ndc)
Application Number
ANDA207018 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 12.5 mg/1
- 300 mg/1
Packaging
- 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-10)
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-13)
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-19)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a2e7c9d1-50c4-4a14-8dd5-8dfc6d63a29a", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "unii": ["0J48LPH2TH", "J0E2756Z7N"], "rxcui": ["310792", "310793"], "spl_set_id": ["181324c5-256f-4570-a0bb-8bc908deb2e2"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-10)", "package_ndc": "29300-216-10", "marketing_start_date": "20180331"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-13)", "package_ndc": "29300-216-13", "marketing_start_date": "20180331"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (29300-216-19)", "package_ndc": "29300-216-19", "marketing_start_date": "20180331"}], "brand_name": "Irbesartan and Hydrochlorothiazide", "product_id": "29300-216_a2e7c9d1-50c4-4a14-8dd5-8dfc6d63a29a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "29300-216", "generic_name": "Irbesartan and Hydrochlorothiazide", "labeler_name": "Unichem Pharmaceuticals (USA), Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "IRBESARTAN", "strength": "300 mg/1"}], "application_number": "ANDA207018", "marketing_category": "ANDA", "marketing_start_date": "20170919", "listing_expiration_date": "20261231"}